Kling Douglas F bought NAMS
January 1, 2024 · Form 4 insider transaction
Kling Douglas F bought 323,771 shares of NewAmsterdam Pharma Company N.V. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
323,771
Price
$0.00
Total value
N/A
InsiderKling Douglas F
RoleOfficer
SecurityOption (right to buy)
Transaction codeA: Grant or award
Transaction dateJanuary 1, 2024
Filing dateJanuary 3, 2024
Shares owned after323,771
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
25% of the shares underlying the option will vest on January 1, 2025, the one-year anniversary of vesting start date, with the remaining shares vesting in equal monthly installments thereafter for three years, subject to the Reporting Person's continued service through each such date.